Dr. David Weidig Addresses Discharge Planning Initiatives in Pulmonary Medicine
David Weidig, MD, System Director of Hospital Medicine, Aurora Medical Group, Milwaukee, WI, says that readmissions are not necessarily a failure of medical treatment, but a failure of psycologic and social support systems for the patient that are not addressed while the patient is hospitalized. Dr Weidig states that the Society of Hospital Medicine's Project BOOST is a program that will allow people to look at tools that address the risks and issues that are key factors in readmission.
This video was taken on May 19, 2013, at the ATS 2013 International Conference in Philadelphia, PA.
An overview of the healthcare systems of Australia, Canada, Denmark, England, France, Germany, Italy, Japan, the Netherlands, New Zealand, Norway, Singapore, Sweden, Switzerland, and the United States.
Hospital leaders express the same concerns heard in Florida, Alabama, and elsewhere since the midterms: refusing to expand Medicaid to the working poor leaves thousands without coverage, and they still come to emergency rooms for routine care. The problem is, the Affordable Care Act assumed that expansion would be universal, and funds to care for the uninsured have dried up.
As the personalized medicine initiative takes shape, word comes that CMS will pay for key genetic tests in lung cancer. This policy shift is a sea change after a long period of frustration for test makers in seeking reimbursement.